Name: BioNTech/Pfizer to seek emergency approval for coronavirus vaccine within days
Brand: politico.eu
SKU: politico-eu-141
Availability: OnlineOnly

critic

BioNTech/Pfizer to seek emergency approval for coronavirus vaccine within days

preview

A study of a phase 3 clinical trial shows the vaccine candidate is 95 percent effective.BioNTech and Pfizer announced on Tuesday that they completed a study of a phase 3 clinical trial of their coronavirus vaccine candidate, showing it's 95 percent effective.They plan to submit data to the European Medicines Agency (EMA) within days, a Pfizer spokesperson confirmed. The companies said they'll also submit an application for emergency authorization with the U.S. Food and Drug Administration (FDA) and other international regulators in the same time frame.In an interview on Tuesday at the , the EMA’s new&nbsp;executive&nbsp;director,&nbsp;Emer Cooke,&nbsp;said she expects a vaccine could be authorized “before the end of the year.”The EMA launched a rolling review of the vaccine’s data at the beginning of October, and Cooke said that the agency has seen the preliminary results from the companies. Still, the actual data has to be reviewed by the agency’s experts: “Everything sounds great, but the devil is in the details,” she said.The agency has also reviewed its processes to make the process as “efficient and effective as possible,” she said.The two drugmakers reached a with the European Commission on November 11 to have up to 300 million doses purchased, following their announcement, via press release on November 9, that their jab was 90 percent effective.Log in to access content and manage your profile. If you do not have a login you can .

A study of a phase 3 clinical trial shows the vaccine candidate is 95 percent effective.BioNTech and Pfizer announced on Tuesday that they completed a study of a phase 3 clinical trial of their coronavirus vaccine candidate, showing it's 95 percent effective.They plan to submit data to the European Medicines Agency (EMA) within days, a Pfizer spokesperson confirmed. The companies said they'll also submit an application for emergency authorization with the U.S. Food and Drug Administration (FDA) and other international regulators in the same time frame.In an interview on Tuesday at the , the...

public

Sarah Wheaton

Jillian Deutsch

Politics. Policy. Power.  Follow the team: http://bit.ly/3uanKDN Download our app: https://politi.co/3ME95gU Find us on Telegram: http://t.me/politicoeurope

politico.eu

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

BioNTech/Pfizer to seek emergency approval for coronavirus vaccine within days

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS